JPH11504644A - 免疫グロブリンの製造 - Google Patents

免疫グロブリンの製造

Info

Publication number
JPH11504644A
JPH11504644A JP8533805A JP53380596A JPH11504644A JP H11504644 A JPH11504644 A JP H11504644A JP 8533805 A JP8533805 A JP 8533805A JP 53380596 A JP53380596 A JP 53380596A JP H11504644 A JPH11504644 A JP H11504644A
Authority
JP
Japan
Prior art keywords
immunoglobulin
pepsin
product
filter
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP8533805A
Other languages
English (en)
Japanese (ja)
Inventor
ヴエリ，ヘルマン スオメラ，ハヌ
ハマライネン，エーロ，オラヴイ
Original Assignee
スオメン プナイネン リステイ ヴエリパルヴエル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スオメン プナイネン リステイ ヴエリパルヴエル filed Critical スオメン プナイネン リステイ ヴエリパルヴエル
Publication of JPH11504644A publication Critical patent/JPH11504644A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/06—Inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8533805A 1995-05-08 1996-05-07 免疫グロブリンの製造 Ceased JPH11504644A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI952196A FI952196A0 (fi) 1995-05-08 1995-05-08 Framstaellning av immunoglobulin
FI952196 1995-05-08
PCT/FI1996/000254 WO1996035710A1 (en) 1995-05-08 1996-05-07 Preparation of immunoglobulin

Publications (1)

Publication Number Publication Date
JPH11504644A true JPH11504644A (ja) 1999-04-27

Family

ID=8543365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8533805A Ceased JPH11504644A (ja) 1995-05-08 1996-05-07 免疫グロブリンの製造

Country Status (9)

Country Link
US (3) US20020128453A1 (de)
EP (1) EP0825998B1 (de)
JP (1) JPH11504644A (de)
AT (1) ATE236926T1 (de)
AU (1) AU700736B2 (de)
DE (1) DE69627319T2 (de)
DK (1) DK0825998T3 (de)
FI (1) FI952196A0 (de)
WO (1) WO1996035710A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332564A1 (de) 1997-02-07 2011-06-15 Stryker Corporation Matrixlose osteogene Vorrichtungen und Implantate und Verfahren zu deren Verwendung
US6124437A (en) * 1997-03-19 2000-09-26 Welfide Corporation Immunoglobulin preparation and preparation process thereof
GB9705810D0 (en) * 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
WO1998044942A1 (de) 1997-04-08 1998-10-15 Baxter Aktiengesellschaft Immuntolerante prothrombinkomplex-präparation
AT406873B (de) * 1998-02-25 2000-10-25 Immuno Ag Verfahren zur abreicherung von pathogenen aus proteinhaltigen lösungen
EP2261230B1 (de) 2002-09-11 2017-05-10 Chugai Seiyaku Kabushiki Kaisha Verfahren zur Proteinreinigung
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
JP4857323B2 (ja) * 2008-10-17 2012-01-18 田辺三菱製薬株式会社 免疫グロブリン製剤
EP3275897A1 (de) 2016-07-27 2018-01-31 Biotest AG Verfahren zur herstellung von immunoglobulinzusammensetzungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography

Also Published As

Publication number Publication date
EP0825998A1 (de) 1998-03-04
ATE236926T1 (de) 2003-04-15
AU700736B2 (en) 1999-01-14
DE69627319T2 (de) 2004-02-12
DE69627319D1 (de) 2003-05-15
WO1996035710A1 (en) 1996-11-14
US20020128453A1 (en) 2002-09-12
DK0825998T3 (da) 2003-08-04
AU5650096A (en) 1996-11-29
US20040106780A1 (en) 2004-06-03
EP0825998B1 (de) 2003-04-09
FI952196A0 (fi) 1995-05-08
US20060177909A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
US4877866A (en) Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation
US20060177909A1 (en) Preparation of immunoglobulin
JP4445202B2 (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
US6307028B1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
CA1341505C (en) Intravenously administered polyclonal immunoglobulin preparation containing igm and method of manufacture
US5300433A (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
AU618157B2 (en) Viral inactivation process
CZ287186B6 (en) Process for preparing concentrate free of aggregation of immunoglobulins G
KR20010052733A (ko) 정맥 주사용 면역글로불린의 제조 방법 및 그 외의면역글로불린 제품
KR20070009995A (ko) 바이러스 안전성 면역글로불린을 제조하는 방법
SK287633B6 (sk) Spôsob výroby humánneho gamaglobulínu G a humánny gamaglobulín G s inaktivovanými vírusmi
CA2283965A1 (en) Composition comprising immunoglobulin
EP0246579B1 (de) Verfahren zur Herstellung von Immunoglobulinzubereitungen für intravenöse Injektion
CN107849086B (zh) 用于制备源自血浆的乙型肝炎免疫球蛋白的方法
CA2232420A1 (en) Immunoglobulin preparation and preparation process thereof
WO1999033486A1 (en) Composition and method for dermal and transdermal administration of a cytokine
RU2198668C2 (ru) Способ получения раствора гамма-глобулина, предназначенного для внутривенного введения, и продукт, получаемый этим способом
JP2952572B2 (ja) ヒト血漿の分別中に得られる画分から免疫グロブリンを回収する方法
JPH0365327B2 (de)
JPH04346934A (ja) γ−グロブリンの液状製剤
AU756071B2 (en) Manufacturing method for intravenous immune globulin and resultant product
JP2008094722A (ja) 免疫グロブリン製剤の製造方法
Hooper et al. Production and properties of intravenous immunoglobulins
JP2618643B2 (ja) 静注用免疫グロブリン製剤
TW201811815A (zh) 製備免疫球蛋白溶液的方法及其用途

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060808

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070206